Elite pharmaceuticals inc stock is down -100% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 38.46% of the previous 25 December’s closed higher than November.
Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, and 30mg tablets for pains under Roxycodone brand.